357 related articles for article (PubMed ID: 15729207)
21. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy in epithelial ovarian cancer.
Wang J; Li AJ; Karlan BY
Curr Womens Health Rep; 2002 Feb; 2(1):20-6. PubMed ID: 12112979
[TBL] [Abstract][Full Text] [Related]
23. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
24. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
Cliby WA; Aletti GD; Wilson TO; Podratz KC
Gynecol Oncol; 2006 Dec; 103(3):797-801. PubMed ID: 17052746
[TBL] [Abstract][Full Text] [Related]
25. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
26. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.
van de Laar R; Zusterzeel PL; Van Gorp T; Buist MR; van Driel WJ; Gaarenstroom KN; Arts HJ; van Huisseling JC; Hermans RH; Pijnenborg JM; Schutter EM; Pelikan HM; Vollebergh JH; Engelen MJ; Inthout J; Kruitwagen RF; Massuger LF
BMC Cancer; 2014 Jan; 14():22. PubMed ID: 24422892
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of second look laparotomy in the management of epithelial ovarian tumors. 88 interventions performed at the Dijon CAC between 1979 and 1990].
Ollivier L; Fraisse J; Barillot I; Mayer F; Maingon P; Cuisenier J
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):838-42. PubMed ID: 8132958
[TBL] [Abstract][Full Text] [Related]
29. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
30. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
[TBL] [Abstract][Full Text] [Related]
31. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
32. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.
Reichman TW; Cracchiolo B; Sama J; Bryan M; Harrison J; Pliner L; Harrison LE
J Surg Oncol; 2005 May; 90(2):51-6; discussion 56-8. PubMed ID: 15844187
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable.
Gadducci A; Ferrero A; Cosio S; Zola P; Viacava P; Dompé D; Fanelli G; Ravarino N; Motta M; Cristofani R; Genazzani AR
Anticancer Res; 2006; 26(5B):3925-32. PubMed ID: 17094423
[TBL] [Abstract][Full Text] [Related]
34. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
[TBL] [Abstract][Full Text] [Related]
36. One year maintenance of carboplatin in patients with epithelial ovarian cancer--a phase II study.
Safra T; Kovner F; Barak N; Inbar MJ; Ron IG
Isr Med Assoc J; 2006 Jan; 8(1):27-9. PubMed ID: 16450747
[TBL] [Abstract][Full Text] [Related]
37. [Our experience in treating ovarian tumors with borderline malignancy].
Ivanov S; Kŭrlov T; Ivanov S
Akush Ginekol (Sofiia); 2000; 39(1):39-41. PubMed ID: 10826337
[TBL] [Abstract][Full Text] [Related]
38. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of progression-free interval in patients with ovarian cancer treated by first-line chemotherapy with paclitaxel and carboplatin].
Lehoczky O; Pulay T
Magy Onkol; 2005; 49(4):315-8. PubMed ID: 16518475
[TBL] [Abstract][Full Text] [Related]
40. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]